Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

SOHO Italy 2021 | SOHO Italy 2021: what to expect

Claudio Cerchione • 9 Sep 2021

SOHO Italy 2021

General

Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, talks on the SOHO (Society of Hematologic Oncology) 3rd Italian Conference, taking place from the 27th to the 30th of September, 2021, and gives an overview of what updates anticipated at this hybrid event. Dr Cerchione also talks about the first day’s satellite symposium where new topics such as artificial intelligence and novel therapies will be discussed. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.

Disclosures

Claudio Cerchione, MD, PhD, has received honoraria from Sanofi, GSK, Janssen, BMS-Celgene, Takeda and Karyopharm.

Key trials in multiple myeloma presented at ASH 2023: take home messages

Claudio Cerchione • 11 Dec 2023

Novel immunotherapies transforming R/R myeloma treatment: bispecifics, CAR-T cells & more

Claudio Cerchione • 28 Sep 2023

Promising triplets and agents in R/R myeloma: SVd, Isa-Kd and melflufen

Claudio Cerchione • 28 Sep 2023

The role of FDG-PET plus whole body MRI in staging patients with high-risk SMM & R/R myeloma

Claudio Cerchione • 28 Sep 2023

Related Videos

Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD

Florent Malard • 11 Apr 2024

Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD

Mohamad Mohty • 17 Apr 2024

HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors

Rémy Duléry • 15 Apr 2024

The consequences of regulatory changes on access to devices and reagents needed for graft processing

Christian Chabannon • 16 Apr 2024